IWC
EPRX

Integrated Wealth Concepts’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Integrated Wealth Concepts’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.9K Buy
+12,000
New +$96.6K ﹤0.01% 2192
2025
Q4 		– Sell
-12,000
Closed -$70.8K – 2067
2025
Q3 		$70.8K Buy
+12,000
New +$65.3K ﹤0.01% 1932

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Integrated Wealth Concepts's EPRX Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q1 2026: 12,000 shares worth $86.9K. The stake represents ﹤0.01% of the portfolio and ranks #2192 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in EPRX as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in EPRX in Q3 2025 and has held it in 2 quarters since. 54 funds tracked by Wall St. Rank hold EPRX as of Q1 2026.

  • Integrated Wealth Concepts held 12,000 shares of Eupraxia Pharmaceuticals worth $86.9K as of Q1 2026.
  • Eupraxia Pharmaceuticals was a new Integrated Wealth Concepts position in Q1 2026.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2192 holding.
  • Integrated Wealth Concepts first reported a position in Eupraxia Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 54 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.